Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.31 USD | +0.22% | -1.22% | +16.65% |
04-24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
04-24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
Evolution of the average Target Price on Centessa Pharmaceuticals plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Centessa Pharmaceuticals plc
Morgan Stanley | |
Guggenheim | |
Goldman Sachs | |
BMO Capital | |
Evercore ISI | |
SVB Securities LLC | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- CNTA Stock
- Consensus Centessa Pharmaceuticals plc